Paper11186331
Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
Chirgwin JM and 1 other. Crit Rev Eukaryot Gene Expr, 2000. Cited by 165 papers, by iCite.
Cite this record
ConductScience Library. Molecular mechanisms of tumor-bone interactions in osteolytic metastases. Papers, record 11186331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11186331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Neoplasms | Major topic |
| Bone and Bones | |
| Breast Neoplasms | |
| Calcium | |
| Gonadal Steroid Hormones | |
| Humans | |
| Lymphocytes | |
| Neovascularization, Pathologic | |
| Osteoclasts | |
| Osteolysis | |
| Parathyroid Hormone-Related Protein | |
| Proteins | |
| Transforming Growth Factor beta |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA40035 | NCI NIH HHS | United States | P01CA040035 | PubMed and NIH | NIH RePORTER |
| CA69158 | NCI NIH HHS | United States | R01CA069158 | PubMed and NIH | NIH RePORTER |
| R29CA069158 | NIH | NIH RePORTER |
Cited by71
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 165 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42775174 | Tumor-nerve crosstalk: peripheral mechanisms mediating bone tumor progression and cancer-induced bone pain. | Front Oncol | 2026 | https://conductscience.org/library/papers/42775174 | PubMed |
| 41596432 | Bone Metastasis in Estrogen Receptor-Positive Breast Cancer: Molecular Insights and Therapeutic Advances. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596432 | PubMed |
| 41249489 | Pharmacological inhibition of myostatin effectively ameliorates osteolytic lesions in syngeneic and xenograft breast cancer mouse models. | Oncogene | 2025 | https://conductscience.org/library/papers/41249489 | PubMed |
| 38427117 | The novel cytotoxic polybisphosphonate osteodex decreases bone resorption by enhancing cell death of mature osteoclasts without affecting osteoclastogenesis of RANKL-stimulated mouse bone marrow macrophages. | Invest New Drugs | 2024 | https://conductscience.org/library/papers/38427117 | PubMed |
| 38148788 | Pain associated with breast cancer: etiologies and therapies. | Front Pain Res (Lausanne) | 2023 | https://conductscience.org/library/papers/38148788 | PubMed |
| 35685372 | Deregulated molecules and pathways in the predisposition and dissemination of breast cancer cells to bone. | Comput Struct Biotechnol J | 2022 | https://conductscience.org/library/papers/35685372 | PubMed |
| 35355564 | Identification of MAGEC2/CT10 as a High Calcium-Inducible Gene in Triple-Negative Breast Cancer. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35355564 | PubMed |
| 34831167 | Mechanisms, Diagnosis and Treatment of Bone Metastases. | Cells | 2021 | https://conductscience.org/library/papers/34831167 | PubMed |
| 34830748 | Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34830748 | PubMed |
| 34268641 | The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies. | Med Oncol | 2021 | https://conductscience.org/library/papers/34268641 | PubMed |
| 32117996 | RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/32117996 | PubMed |
| 30151009 | PTH1R-CaSR Cross Talk: New Treatment Options for Breast Cancer Osteolytic Bone Metastases. | Int J Endocrinol | 2018 | https://conductscience.org/library/papers/30151009 | PubMed |
| 29747461 | Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/29747461 | PubMed |
| 29644008 | Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma. | Oncotarget | 2018 | https://conductscience.org/library/papers/29644008 | PubMed |
| 29088893 | Clinical study of 99mTc-3P-RGD2 peptide imaging in osteolytic bone metastasis. | Oncotarget | 2017 | https://conductscience.org/library/papers/29088893 | PubMed |
| 28799237 | Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma. | Cancer Med | 2017 | https://conductscience.org/library/papers/28799237 | PubMed |
| 28764683 | Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients. | BMC Cancer | 2017 | https://conductscience.org/library/papers/28764683 | PubMed |
| 28504970 | Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity. | Oncotarget | 2017 | https://conductscience.org/library/papers/28504970 | PubMed |
| 28078478 | Hypercalcaemia and hypocalcaemia: finding the balance. | Support Care Cancer | 2017 | https://conductscience.org/library/papers/28078478 | PubMed |
| 28071724 | Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer. | Sci Rep | 2017 | https://conductscience.org/library/papers/28071724 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| PTHLH | 5744 | PubTator's text mining | https://conductscience.org/library/genes/5744 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11186331
GET https://conductscience.org/api/papers/v1/11186331/cited_by?page=2